Chrysovergis Aristeidis, Papanikolaou Vasileios, Roukas Dimitrios, Spyropoulou Despoina, Mastronikoli Sofianiki, Papouliakos Sotirios, Tsiambas Evangelos, Pantos Pavlos, Fotiades Panagiotis, Peschos Dimitrios, Ragos Vasileios, Mastronikolis Nicholas, Kyrodimos Efthymios, Niotis Athanasios
Department of Otorhinolaryngology, "ELPIS" Hospital, Athens, Greece.
Department of Otorhinolaryngology, "SOTIRIA", Hospital, Athens, Greece.
Maedica (Bucur). 2024 Dec;19(4):842-847. doi: 10.26574/maedica.2024.19.4.842.
MicroRNAs (miRs) are crucial micro-genetic markers that significantly manipulate gene expression in neoplastic/malignant and non-neoplastic diseases, as viral infections. Different expression patterns of miRs seem to partially influence the response rates to specific chemo-targeted therapeutic regimens and prognosis in cancer patients. Concerning their nature, miRs are short non-coding RNAs including 20-25 nucleotides hosted in intra- or intergenic regions. Their most important function is the positive regulation of post-transcriptional gene silencing levels. Based on this activity, they enhance normal cell functions, including proliferation, apoptosis and tissue differentiation. Their deregulation in cancerous cells due to epigenetic and transcriptional imbalances is correlated with an excessive production of target mRNA.
In the current paper, our aim was to generally describe the role of MiRs in cancer genome and we mainly focused on specific host target-cell miRs that are affected by SARS-CoV-2 in the COVID-19 pandemic.
A systematic review of the literature was carried out based on the international database PubMed focused on miR nature, origin, structure and function in cancer genome and more recently on the influence of SARS-CoV-2 on affected cells. The following keywords were used: microRNA, SARS-CoV-2, COVID-19, infection, cancer, virus. A pool of 52 important articles were selected for the present review at the basis of exploring the SARS-CoV-2 efficacy in miRs.
A broad set of miRs, including miR-122, miR-16-2-3p, miR-3605-3p, miR-15b-5p, miR-486-3p, miR-486-5p, miR-447b, miR-3672, miR-325, miR-447b and miR-222, has been identified to be deregulated by SARS-CoV-2 infection.
miRs represent significant micro-epigenetic markers frequently deregulated in SARS-CoV-2 mediated infection (COVID-19). Interactions between miRs and SARS-CoV-2 RNA genome are under investigation. miR overexpression/expression loss in SARS-CoV-2 affected epithelia is correlated with specific genetic and by epigenetic signatures in the corresponding patients.
微小RNA(miRs)是至关重要的微观遗传标记,在肿瘤/恶性疾病以及病毒感染等非肿瘤性疾病中显著调控基因表达。miRs的不同表达模式似乎部分影响癌症患者对特定化学靶向治疗方案的反应率和预后。就其本质而言,miRs是短的非编码RNA,包含20 - 25个核苷酸,位于基因内或基因间区域。它们最重要的功能是对转录后基因沉默水平进行正向调控。基于此活性,它们增强正常细胞功能,包括增殖、凋亡和组织分化。由于表观遗传和转录失衡,它们在癌细胞中的失调与靶mRNA的过量产生相关。
在本文中,我们的目的是总体描述miRs在癌症基因组中的作用,并且主要关注在新冠疫情中受严重急性呼吸综合征冠状病毒2(SARS-CoV-2)影响的特定宿主靶细胞miRs。
基于国际数据库PubMed对文献进行系统综述,重点关注miRs在癌症基因组中的性质、起源、结构和功能,以及最近SARS-CoV-2对受影响细胞的影响。使用了以下关键词:微小RNA、SARS-CoV-2、2019冠状病毒病、感染、癌症、病毒。在探索SARS-CoV-2在miRs中的作用效果的基础上,选择了52篇重要文章用于本综述。
已确定一组广泛的miRs,包括miR-122、miR-16-2-3p、miR-3605-3p、miR-15b-5p、miR-486-3p、miR-486-5p、miR-447b、miR-3672、miR-3-25、miR-447b和miR-222,因SARS-CoV-2感染而失调。
miRs是在SARS-CoV-2介导的感染(2019冠状病毒病)中经常失调的重要微观表观遗传标记。miRs与SARS-CoV-2 RNA基因组之间的相互作用正在研究中。SARS-CoV-2感染的上皮细胞中miR的过表达/表达缺失与相应患者的特定基因和表观遗传特征相关。